Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OPRX
#3141
OptimizeRx Corporation Common Stock
7.5
8
-2.82%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-2.82%
Changement Mensuel
-35.82%
Evolution sur 6 mois
-56.78%
Changement Annuel
+46.05%
Clôture Précédente
7.8
0
Open
7.5
8
Bid
Ask
Low
7.5
8
High
7.5
8
Volume
33
Marchés
Actions des Marchés US
Soins de Santé
OPRX
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
18.42 M
18.49 M
18.5 M
18.57 M
18.64 M
—
Valuation ratios
Enterprise value
126.08 M
76.48 M
143.59 M
234.04 M
362.61 M
816.74 M
Price to earnings ratio
-5.72
-4.42
-10.31
-25
-184.65 P
-184.65 P
Price to sales ratio
1.56
0.97
1.68
2.39
3.52
8.55
Price to cash flow ratio
-34.63
18.18
24.02
24.21
32.83
99.24
Price to book ratio
0.29
0.76
0.34
0.54
0.81
2.45
Enterprise value to EBITDA ratio
-5.05
-8.95
-29.58
161.74
30.09
153.31
Profitability ratios
Return on assets %
0.06
0
0.01
0.01
0
0.03
Return on equity %
0.08
0
0.02
0.01
0.01
0.04
Return on invested capital %
21.15
-3.12
4.08
8.78
4.69
14.43
Gross margin %
63.1
68.15
60.85
63.83
67.2
260.03
Operating margin %
40.18
-11.25
9.64
10.92
7.86
17.18
EBITDA margin %
-39.33
25.19
-8.85
12.42
8.53
37.29
Net margin %
42.82
0.24
10.03
5.25
2.99
18.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.23
2.89
2.82
2.57
3.05
11.33
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.13
0.19
0.13
0.17
0.15
0.65
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.2
0.18
0.17
0.15
0.15
0.65
Long term debt to total equity ratio
0.29
0.26
0.25
0.21
0.2
0.93
Per share metrics
Operating cash flow per share
0.1
0.01
0.21
0.24
0.16
0.62
EBIT per share
-0.47
0.2
-0.11
0.17
0.11
0.36
EBITDA per share
-0.46
0.45
-0.11
0.19
0.11
0.64
Total debt per share
—
—
—
—
—
—
Cash per share
0.88
0.73
1.35
1.32
1.44
4.84
Net current asset value per share
2.56
2.95
2.8
2.84
2.89
11.49
Tangible book value per share
2.07
2.52
2.17
2.27
2.38
9.35
Working capital per share
1.77
1.93
1.81
1.74
1.95
7.42
Book value per share
6.25
6.4
6.29
6.27
6.28
25.25
Nouvelles
Intuit (INTU) Q2 Earnings and Revenues Top Estimates
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript
OptimizeRx превзошла ожидания по прибыли в 3 квартале 2025 года
Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates
OPTIMIZERx earnings beat by $0.16, revenue topped estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
Целевая цена OptimizeRX повышена до $23 с $20 в Citizens
OptimizeRX price target raised to $23 from $20 at Citizens